Abstract
A number of viruses, most notably herpes virus type 2, have been suggested as etiological agents of cervical neoplasia. Recent studies with human papillomaviruses, however, have demonstrated a remarkable association of a subgroup of these viruses with about 90% of benign, preinvasive and invasive lesions of the cervix and anogenital tract. The oncogenic potential of papillomaviruses has been demonstrated both in laboratory animals and in cultured cells. Furthermore, susceptibility to certain human papillomaviruses has been associated with a recessive genetic defect that results in squamous cell carcinoma of the skin. The human papillomaviruses are difficult to study, however, because of the lack of an animal model, difficulty in developing a tissue culture system permissive for their replication, and a lack of understanding of their biology. Current understanding of the natural history of anogenital neoplasia may provide insights into the mechanisms the host uses to cope with potentially oncogenic human papillomaviruses.
Similar content being viewed by others
References
Rotkin ID: A comparison review of key epidemiological studies in cervical cancer related to current searches for transmissible agents. Cancer Res 33: 1353–1367, 1973
Kurman RJ, Shah KH; Lancaster WD, Jenson AB: Immunoperoxidase localization of papillomavirus antigens in cervical dysplasia and vulvar condylomas. Am J Obstet Gynecol 140: 931–935, 1981
Lancaster WD, Kurman RJ, Sanz LE, Perry S, Jenson AB: Human papillomavirus: Detection of viral DNA sequences and evidence for molecular heterogeneity in metaplasias and dysplasias of the uterine cervix. Intervirol 20: 202–212, 1983
Gissmann L, Wolnik L, Ikenberg H, Koldovsky U, Schnurch HG, zur Hausen H: Human papillomavirus types 6 and 11 DNA sequences in genital and laryngeal papillomas and in some cervical cancers. Proc Natl Acad Sci USA 80: 560–563, 1983
Durst M, Gissmann L, Ikenberg H, zur Hausen H: A papillomavirus DNA from a cervical carcinoma and its prevalence in cancer biopsy samples from different geographic regions. Proc Natl Acad Sci USA 80: 3812–3815, 1983
Boshart M, Gissmann L, Ikenberg H, Kleinheinz A, Scheurlen W, zur Hausen H: A new type of papillomavirus DNA, its presence in genital cancer biopsies and in cell lines derived from cervical cancer. EMBO J 3: 1151–1157, 1984
Lorincz AT, Lancaster WD, Kurman RJ, Jenson AB, Temple GF: Characterization of human papillomaviruses in cervical neoplasias and their detection in routine clinical screening. In: Peto R, zur Hausen H (eds) Banbury Report 21: The Viral Etiology of Cervical Cancer. Cold Spring Harbor Laboratory, N.Y., 1986, pp 225–237
Lancaster WD, Castellano C, Santos C, Delgado G, Kurman RJ, Jenson AB: Human papillomavirus deoxyribonucleic acid in cervical carcinoma from primary and metastatic sites. Am J Obstet Gynecol 154: 115–119, 1986
Yee C, Krishnan-Hewlett I, Baker CC, Schlegel R, Howley PM: Presence and expression of human papillomavirus sequences in human cervical carcinoma cell lines. Am J Pathol 119: 361–366, 1985
Rous P, Beard JW: The progression to carcinoma of virus-induced rabbit papillomas (Shope). J Exp Med 62: 523–548, 1935
Orth G, Jablonska S, Jarzabek-Chorzelska M, Rzesa G, Obalek S, Favre M, Croissant O: Characteristics of the lesions and risk of malignant conversion as related to the type of the human papillomavirus involved in epidermodysplasia verruciformis. Cancer Res 39: 1074–1082, 1979
Orth G, Favre M, Breithburd F, Croissant O, Obalek S Jarzabek-Chorzelska M, Rzesa G: Epidermodysplasia verruciformis: A model for the role of papilloma viruses in human cancer. Cold Spring Harbor Conf Cell Prolif 7: 259–282, 1980
Ostrow RA, Bender MA, Niimura M, Sekki T, Kawashima M, Pass F, Faras AJ: Human papillomavirus DNA in cutaneous primary and metastasized squamous cell carcinomas from patients with epidermodysplasia verruciformis. Proc Natl Acad Sci USA 79: 1634–1638, 1982
Majoros M, Devine KD, Parkhill EM: Malignant transformation of benign laryngeal papillomas in children after radiation therapy. Surg Clin N Am 43: 1049–1061, 1963
Boxer RJ, Skinner DG: Condyloma acuminata and squamous carcinoma. Urology 9: 72–78, 1977
Lorincz AT, Temple GF, Kurman RJ, Jenson AB, Lancaster WD: The oncogenic association of specific HPV; types with cervical neoplasia. J Natl Cancer Inst 79: 671–677, 1987
Lorincz AT, Lancaster WD, Temple GF: Cloning and characterization of the DNA of a new human papillomavirus from a woman with dysplasia of the uterine cervix. J Virol 58: 225–229, 1986
Cole ST, Streeck RE: Genome organization and nucleotide sequence of human papillomavirus type 33, which is associated with cervical cancer. J Virol 58: 991–995, 1986
Lorincz AT, Quinn AP, Lancaster WD, Temple GF: A new type of papillomavirus associated with cancer of the uterine cervix. J Virology 159: 187–190, 1987
Bangle R, Berger M, Levin M: Variations in the morphogenesis of squamous carcinoma of the cervix. Cancer 16: 1151–1159, 1963
Lorincz AT, Temple GF, Patterson JA, Jenson AB, Kurman RJ, Lancaster WD: Correlation of cellular atypia and human papillomavirus DNA sequences in exfoliated cells of the uterine cervix. Obstet Gynecol 68: 508–512, 1986
Lancaster WD, Meinke W: Peristence of viral DNA in human cell cultures infected with human papilloma virus. Nature 256: 434–436, 1975
LaPorte RF, Taichman L: Human papilloma viral DNA replicates as a stable episome in cultured epidermal keratinocytes. Proc Natl Acad Sci, USA 79: 3393–3397, 1982
Ferenczy A, Mitao M, Nagai N, Silverstein SJ, Crum CP: Latent papillomavirus and recurring genital warts. N Engl J Med 313: 784–788, 1985
Steinberg BM, Topp WC, Schneider PS, Abramson AL: Laryngeal papillomavirus in clinically and histologically normal tissue. N Engl J Med 308: 1261–1264, 1983
Kistner RW, Hertig AT: Papillomas of the uterine cervix: Their malignant potentiality. Obstet. Gynecol. 6: 147–161, 1955
Kurman RJ, Jenson AB, Lancaster WD: Papillomavirus infection of the cervix. II. Relationship to intraepithelial neoplasia based on the presence of specific viral structural proteins. Am J Surg Pathol 7: 39–52, 1983
Stevens JG, Wagner EK, Devi-Rao GB, Cook ML, Feldman TL: RNA complementary to a herpes virus alpha gene mRNA is prominent in latently infected neurons. Science 235: 1956–1059, 1987
Yang Y, Okayama H, Howley PM: Bovine papillomavirus contains multiple transforming genes. Proc Natl Acad Sci USA 82: 1030–1034, 1985
Stenlund A, Zabielski J, Ahola H, Moreno-Lopex J, Pettersson U: Messenger RNAs form the transforming region of bovine papilloma virus type 1. J Mol Biol 182: 541–554, 1985
Smotkin D, Wettstein FO: Transcription of human papillomavirus type 16 early genes in a cervical cancer and a cancer-derived cell line and identification of the E7 protein. Proc Natl Acad Sci, USA 83: 4680–4684, 1986
Nasseri M, Wettstein FO: Differences exist between viral transcripts in cottontail rabbit papillomavirus-induced benign and malignant tumors as well as non-virus-producing tumors. J Virol 51: 706–712, 1984
Chen EY, Howley PM, Levinson AD, Seeberg PH: The primary structure and genetic organization of bovine papillomavirus type 1. Nature 299: 529–534, 1982
Danos O, Katinka M, Yaniv M: Human papillomavirus 1a complete DNA sequence: A novel type of genome organization among papovariridae. EMBO J 1: 231–236, 1982
Yang YC, Spalholz BA, Rabson MS, Howley PM: Dissociation of transforming andtrans activation functions for bovine papillomavirus type 1. Nature 318: 75–577, 1985
Groff DE, Lancaster WD: Genetic analysis of the 3′ early region transformation and replication functions of bovine papillomavirus type 1. Virology 150: 221–230, 1986
DiMaio D, Guralski D, Schiller JT: Translation of open reading frame E5 of bovine papillomavirus is required for its transforming activity. Proc Natl Acad Sci USA 83: 1797–1801, 1986
Schiller JT, Vass WC, Vousden KH, Lowy DR: E5 open reading frame of bovine papillomavirus type 1 encodes a transforming gene. J. Virol 57: 1–6, 1986
Androphy EJ, Schiller JT, Lowy DR: Identification of the protein encoded by the E6 transforming gene of bovine papillomavirus. Science 230: 442–445, 1985
Berman A, Winkelmann RK: Flat warts undergoing involution: Histopathologic findings. Arch Dermatol 113: 1219–1221, 1977
Iwatsuki K, Tagami H, Takigawa M, Yamada M: Plane warts under spontaneous regression: Immunopathologic study of cellular constitutents leading to the inflammatory reaction. Arch Dermatol 122: 655–659, 1986
Tagami H, Oku T, Iwatsuki K: Primary tissue culture of spontaneously regressing falt warts:In vitro attack by mononuclear cells against wart-derived epidermal cells. Cancer 55: 2437–2441, 1985
Lack EE, Jenson AB, Smith HG, Healy GB, Pass F, Vawter GF: Immunoperoxidase localization of human papillomavirus in laryngeal papillomas. Intervirol 14: 148–154, 1980
Gal AA, Meyer PR, Taylor CR: Papillomavirus antigens in anorectal condyloma and carcinoma in homosexual men. J Am Med Assoc 257: 337–340, 1987
Evans CA, Ito Y: Antitumor immunity in the Shope papilloma-carcinoma complex. III. Response to reinfection with viral nucleic acid. J Natl Cancer Inst 36: 1161–1166, 1966
Evans CA, Weiser RS, Ito Y: Antiviral and antitumor immunological mechanisms operative in the Shope papilloma carcinoma system. Cold Spring Harbor Symp Quant Biol 27: 453–462, 1963
Baird PJ: Serological evidence for the association of papillomavirus and cervical neoplasia. Lancet ii: 17–18, 1983
Orth G, Breitburd F, Favre M: Evidence for antigenic determinants shared by the structural polypepetides of (Shope) rabbit papillomavirus and human papillomavirus type 1. Virology 91: 243–255, 1978
Zinkernagel RM, Doherty PC: MHC-restricted cytotoxic T cells: Studies of the biological role of polymorphic major transplantation antigens determining T cell restriction-specificity, function and responsiveness. Adv Immunol 27: 51–77, 1979
Powell LC, Pollard M, Jenkins JL: Treatment of condylomata acuminata by autogenous vaccine. South Med J 63: 202–205, 1970
Bernards R, Schrier PI, Houweling A, Bos JL, van der Eb AJ, Zijlstra M, Melief CJM: Tumorigenicity of cells transformed by adenovirus type 12 by evasion of T-cell immunity. Nature 305: 776–779, 1983
Tanaka K, Hayashi H, Hamada C, Khoury G, Jay G: Expression of the major histocompatibility of immune recognition. Proc Natl Acad Sci USA 83: 8723–8727, 1986
Tanaka K, Isselbacher KJ, Khoury G, Jay G: Reversal of oncogenesis by the expression of a major histocompatibility complex class I gene. Science 228: 26–30, 1985
Houweling A, van der Elsen PJ, van der Eb AJ: Partial transformation of primary rat cells by the left-most 4.5% fragment of adenovirus 5 DNA. Virology 105: 537–550, 1980
Lee WMF, Schwab M, Westaway D, Varmus H: Augmented expression of normalc-myc is sufficient for cotransformation of rat embryo cells with a mutantras gene. Mol Cell Biol 5: 3345–3356, 1985
Butel JS: Studies with human papilloma virus modeled after known papovavirus systems. J Natl Cancer Inst 48: 285–299, 1972
Pirisi L, Yasumoto S, Feller M, Doniger J, DiPaulo Jr: Transformation of human fibroblasts and keratinocytes with human papillomavirus type 16 DNA. J Virol 61: 1061–1066, 1987
Land H, Parada L, Weinberg RA: Tumorigenic conversion of primary embryo fibroblasts requires at least two cooperating oncogenes. Nature 304: 596–602, 1983
Ruley H: Adenovirus early region IA enables viral and cellular transforming genes to transform primary cells in culture. Nature 304: 602–606, 1983
Lancaster WD: Apparent lack of integration of bovine papillomavirus DNA in virus-induced equine and bovine tumor cells and virus-transformed mouse cells. Virology 108: 251–255, 1981
Law M-F, Lowy DR, Dvoretzky I, Howley PM: Mouse cells transformed by bovine papillomavirus contain only extrachromosomal viral DNA sequences. Proc Natl Acad Sci USA 78: 2727–2731, 1981
Groff DE, Sundberg JP, Lancaster WD: Extrachromosomal deer fibromavirus DNA in deer fibromas and virus-transformed mouse cells. Virology 131: 546–550, 1983
Wettstein FO, Stevens JG: Variable-sized free episomes of Shope papilloma virus DNA are present in all non-virus-producing neoplasms and integrated episomes are detected in some. Proc Natl Acad Sci USA 79: 790–794, 1982
McVay P, Fretz M, Wettstein F, Stevens J, Ito Y: Integrated Shope virus DNA is present and transcribed in the transplantable rabbit tumor Vx-7. J Gen Virol 60: 271–278, 1982
Gissmann L, Schwartz E: Persistence and expression of human papillomavirus DNA in genital cancer. In: Evered D, Clark C (eds). Papillomaviruses. John Wiley, Chichester, 1986, pp 190–197
Durst M, Kleinheinz A, Holz M, Gissmann L: The physical state of human papillomavirus type 16 DNA in benign and malignant genital tumours. J Gen Virol 66: 1515–1522, 1985
Shimoda K, Lancaster WD: Integration of human papillomavirus sequences in mild cervical dysplasia. Cancer Cell 5: 349–357, 1987
Durst M, Schwartz E, Gissmann L: Integration and persistence of human papillomavirus DNA in genital tumors. In: Peto R, zur Hausen H (eds) Banbury report 21: Viral Etiology of Cervical Cancer, Cold Spring Harbor Laboratory, N.Y., 1986, pp 281–290
Schwarz E, Freese UK, Gissmann L, Mayer W, Roggenbuck, Stremlau A, zur Hausen H: Structure and transcription of human papillomavirus sequences in cervical carcinoma cells. Nature 341: 111–114, 1985
Durst M, Croce C, Gissmann L, Schwarz E, Huebner K: Papillomavirus sequences integrate near cellular oncogenes in some cervical cancers. Proc Natl Acad Sci USA 84: 1070–1074, 1987
Popescu NC, Amsbaugh SC, DiPaulo J: Human papillomavirus type 18 DNA is integrated at a single chromosome site in cervical carcinoma cell line SW756. J Virol 61: 1682–1685, 1987
Riou GF, Barrois M, Dutronquay V, Orth G: Presence of papillomavirus DNA sequences, amplification ofc-myc and c-Ha-ras oncogenes and enhanced expression ofc-myc in carcinomas of the uterine cervix. In: Howley PM, Broker TR (eds) Papillomaviruses: Molecular and Clinical Aspects, Alan R. Liss, N.Y., 1985, pp 47–56
Rando RF, Sedlacek TV, Hunt J, Jenson AB, Kurman RJ, Lancaster WD: Verrucous carcinoma of the vulva associated with an unusual type 6 human papillomavirus. Obstet Gynecol 76: 70S-75S, 1986
Rando RF, Groff DE, Chirkjian JG, Lancaster WD: Isolation and characterization of a novel human papillomavirus type 6 DNA from an invasive vulvar carcinoma. J Virol 57: 353–356, 1986
Boshart M, zur Hausen H: Human papillomaviruses in Buschke-Lowenstein tumors: Physical state of the DNA and identification of a tandem duplication in the noncoding region of a human papillomavirus type 6 subtype. J Virol 58: 963–966, 1986
Rando RF, Lancaster WD, Han P, Lopez C: The noncoding region of HPV-6vc contains two distinct transcriptional enhacing elements. Virology 155: 545–556, 1986
Bishop JM: Cellular oncogenes and retroviruses. Ann Rev Biochem 52: 301–354, 1983
Lutzner MA: Epidermodysplasia verruciformis. Bull Cancer 65: 169–182, 1978
Lutzner M, Croissant O, Ducasse M-F, Kreis H, Crosnier J, Orth G: A potentially oncogenic human papillomavirus (HPV-5) found in two renal allograft recipients. J Invest Dermatol 75: 353–356, 1980
Furgyik S, Grubb R, Kullander S, Sandahl B, Winegerup L, Eydal A: Familial occurrence of cervical cancer, stages O-IV. Acta Obstet Gynecol Scand 65: 223–227, 1986
Silverberg E, Lubera J: Cancer Statistics, 1986. Ca 36: 9–25, 1986
Figge DC, Bennington JL, Schweid AI: Cervical cancer after initial negative and typical vaginal cytology. Am J Obstet Gynecol 108: 422–428, 1970
Dunn JE Jr, Crocker DW, Rube IF, Erickson CC, Coleman SA: Cervical cancer occurrence in Memphis and Shelby County, Tennessee, during 25 years of its cervical cytology screening program. Am J Obstet Gynecol 150: 861–864, 1984
Dunn JE, Schweitzer V: The relationship of cervical cytology to the incidence of invasive cervical cancer and mortality in Alameda County, California, 1960 to 1974. Am J Obstet Gynecol 139: 868–876, 1981
Bain RW, Crocker DW: Rapid onset of cervical cancer in an upper socioeconomic group. Am J Obstet Gynecol 146: 366–371, 1983
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Lancaster, W.D., Jenson, A.B. Natural history of human papillomavirus infection of the anogenital tract. Cancer Metast Rev 6, 653–664 (1987). https://doi.org/10.1007/BF00047472
Issue Date:
DOI: https://doi.org/10.1007/BF00047472